Detected ·
CORE Biomedicine, Inc.
——
CORE Biomedicine, Inc., a Cambridge-based precision oncology biotech, has secured Series A financing with UTokyo IPC participating as co-lead investor.
- Website
- corebiomedicine.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-29 08:10:21 UTC
- Signal ID
- 689c9f74-ce3c-44ef-8cda-46782aaa60c8
As the API returns it
{
"id": "689c9f74-ce3c-44ef-8cda-46782aaa60c8",
"created_at": "2026-07-29T08:10:21.031135Z",
"company_name": "CORE Biomedicine, Inc.",
"company_website_url": "corebiomedicine.com",
"company_linkedin_url": "https://www.linkedin.com/company/core-biomedicine-inc",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*CORE Biomedicine, Inc., a Cambridge-based precision oncology biotech, has secured Series A financing with UTokyo IPC participating as co-lead investor.*"
}